20250186609. Sialic-acid Ligand D (AVICEDA OPHTHALMICS, .)
SIALIC-ACID LIGAND DECORATED THERAPEUTICS
Abstract: the present disclosure provides methods and compositions for modulating the activity of self-associated molecular pattern recognition receptors such as for example, siglec (sialic-acid-binding immunoglobulin-type lectins) and complement factor h (cfh). modulating the activity of infectious organisms such as viral influenza a, b, c, sars-cov1, 2, and cancer/tumor cells such as lung, breast and skin cancers. the compositions comprise a particle, comprising a molecule represented by the following structural formula:
Inventor(s): Michael Tolentino, Derek Y Kunimoto, Anitha Krishnan, Mohamed A. Genead, Rajesh Shinde, Gerardus J.P.H. Boons, Quiang Liu, Anthony R. Prudden, Pradeep Chopra
CPC Classification: A61K47/6937 (the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit)
Search for rejections for patent application number 20250186609
- Patent Applications
- AVICEDA OPHTHALMICS, INC.
- CPC A61K47/6937
- Michael Tolentino of Lakeland FL US
- Derek Y Kunimoto of Paradise Valley AZ US
- Anitha Krishnan of Braintree MA US
- Mohamed A. Genead of Newton Center MA US
- Rajesh Shinde of Lexington MA US
- Gerardus J.P.H. Boons of Athens GA US
- Quiang Liu of Zhongshan City CN
- Anthony R. Prudden of Athens GA US
- Pradeep Chopra of Athens GA US